The present study has addressed for the first time the effect of the peptidergic and highly specific JNK inhibitor XG-102 on TNBS- induced acute colon inflammation, a disease model which shares pathophysiological properties of Crohn's disease [38], [39], [42], [43]. Here, MAPK8 is linked to Crohn disease.